Trial
NCT01655823
The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Wex Pharmaceuticals Inc.
Collaborators
Premier Research
Condition
Pain
Intervention
Placebo
Why stopped
Interim analysis completed and decided to terminate and proceed to Phase 3 trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-30